Objective: Cardiac surgery and cardiopulmonary bypass (CPB) induce an acute inflammatory response contributing to postoperative morbidity. The use of steroids as antiinflammatory agents in surgery using CPB has been tested in many trials and has been shown to have good anti-inflammatory effects but no clear clinical advantages for the lack of an adequately powered sample size. The aim of this study was to evaluate the effects of steroid treatment on mortality and morbidity after cardiac surgery.
C
ARDIAC SURGERY and cardiopulmonary bypass (CPB) induce a systemic acute inflammatory response characterized by leukocytes, platelets and complement activation, and elevated levels of inflammatory mediators 1 that may contribute to postoperative complications including myocardial dysfunction, 2 atrial fibrillation, 3 acute lung injury, 4 and postoperative bleeding. 5 Since the 1960s, 6 several small clinical trials have investigated the effectiveness of steroids to attenuate the inflammatory response; however, there is a lack of evidence about the efficacy of steroids to prevent the occurrence of postoperative complications because of the small sample sizes of these studies.
A systematic review of the literature was performed to determine the effects of steroid prophylaxis on hospital mortality and the incidence of postoperative infections, atrial fibrillation, length of mechanical ventilation, intensive care unit (ICU) stay, overall hospital stay, postoperative blood loss, and re-exploration for bleeding after cardiac surgery.
METHODS
An initial search for clinical trials evaluating the effects of steroid prophylaxis in cardiac surgical patients was performed through PubMed and Cochrane databases from 1966 to January 2009. The searches on both PubMed and Cochrane databases were restricted to clinical trials. The #1 search was "glucocorticoid or steroid or hydrocortisone or dexamethasone or methylprednisolone" (Cochrane: 15,644 citations, PubMed: 46,028 citations), and the #2 search was "cardiac surgery," or "coronary surgery," or "valve surgery," or "cardiopulmonary bypass" (Cochrane: 4,860 citations, PubMed: 5,381 citations). The #3 search combined the #1 and the #2 searches (Cochrane: 168 citations, PubMed: 229 citations). The #4 search was "infant or congenital or pediatric or paediatric or children or neonatal" (Cochrane: 63,452 citations, PubMed: 76,342 citations). The last search combined the #3 research and not the #4 (Cochrane: 136 citations, PubMed: 194 citations). Citations found through this process (PubMed: 194 citations, Cochrane: 136 citations) were independently examined at a title/abstract level by 3 trained researchers (GC, CR, and DP) to select trials involving human adult patients undergoing elective cardiac surgery and receiving pre-or intraoperative steroid prophylaxis. Moreover, a screening of reference lists of the selected articles and pertinent reviews was performed to identify other possible studies. At the end of this process, 104 articles 6-109 were identified and analyzed in depth. At this step, exclusion criteria were as follows: (1) a lack of any data regarding the clinical endpoints, 6-48 (2) a combination of other confounding treatments (eg, different anesthetic protocols or inotropes) to steroid prophylaxis, 49-53 (3) a lack of a placebo group, 54, 55 (4) studies performed on a cohort of patients previously used for another trial, 56 and (5) lack of a randomized doubleblind design. Figure 1 depicts the flow chart of this selection process performed according to Quality of Reporting of Meta-analyses (QUOROM) guidelines. 110 Finally, 31 randomized double-blind trials (RDBs) 79-109 and 1,974 patients fulfilled the criteria and were included in this meta-analysis.
Quality assessment of the trials was obtained using the Jadad score. 111 Because all studies included were randomized and double blind, none of them had a Jadad score lower than 2. Four studies were assessed as relatively poor (score 2), and the remaining were considered good or excellent (score 3-5). Outcome measures were abstracted from each trial by 2 independent researchers (GC and CR). The divergences about quality assessment and abstracted data were resolved by a third author (DP).
Study Design
Summary characteristics of included studies are depicted in Table 1 . Twenty-one trials included patients undergoing isolated coronary artery bypass graft (CABG) surgery, 4 trials CABG surgery or valve surgery, 3 trials only valve surgery, and 3 mixed cardiac operations with the use of CPB. The overall percentage of patients undergoing isolated CABG surgery was 80%. The primary endpoints of the included trials were classified into 3 groups: clinical, biologic (laboratory analyses; ie, the assay of inflammatory markers), and physiologic (instrumental measurements; ie, hemodynamic or respiratory parameters). The most common (58.1%) primary endpoint among the trials was biologic followed by clinical endpoints (29%) and physiologic endpoints (12.9%). Almost half of the patients enrolled in the meta-analysis (44.4%) belonged to 4 RDB trials. 86,95,100,107 Sixteen of 31 trials included diabetic patients. 79, [82] [83] [84] 88, 90, 92, 93, 95, 96, 102, 103, [106] [107] [108] [109] In those studies, the incidence of diabetic patients ranged between 15% and 30%; none of the studies was conducted only on diabetics.
Of the 31 RDBs, 3 had multiple intervention arms 81, 88, 96 evaluating different steroids or different dosages of the same steroid. Thus, according to Cochrane guidelines, 112 in order to achieve independent comparisons between each intervention group and placebo, patients belonging to the placebo group were divided into subgroups of equal size that were compared with each intervention group of those trials. In this way, the total number of patients belonging to the placebo group remained the same. Thus, from the original 31 trials considered, 35 comparisons between intervention and placebo groups were included, and, therefore, of 1,974 total patients, 1,020 underwent steroid prophylaxis and 954 were given placebo. Table 2 describes the type of steroid used in the selected trials and the number of patients who underwent each treatment. In the majority of 
Definitions
The following endpoints were defined as follows: postoperative mortality was considered as all-cause mortality occurring up to 30 days postoperatively or before hospital discharge. New onset of atrial fibrillation was considered if it occurred before hospital discharge. The length of intubation was measured in minutes, ICU stay was measured in hours, and overall stay was measured in days. Postoperative infections include any type of infection that occurred after surgery. Postoperative chest tube drainage was measured in milliliters.
Statistical Analysis
Categoric variables were presented as absolute numbers (percentages), whereas continuous variables were presented as mean Ϯ standard deviation. In case the continuous data abstracted from the trials had been presented differently from mean Ϯ standard deviation, they were transformed into mean Ϯ standard deviation according to the directions of the Cochrane Handbook 112 before being analyzed.
Effect sizes measured were odds ratio (OR) for categoric variables and mean difference (MD) for continuous variables. The I 2 test was used to evaluate statistical heterogeneity. An I 2 Ͻ25% was considered low heterogeneity. However, because of a noticeable clinical heterogeneity caused by the use of different types and doses of steroids in each trial, the random-effect model was used to perform all meta-analyses. Continuity correction was calculated according to the "reciprocal of the opposite treatment arm size" method in case of 0 cells, whereas trials without any event in both treatment and control groups ("zero-sum" trials) were excluded from calculations. Analyses were performed using Meta-analysis with Interactive Explanation Software (Version 1.61 for Windows; Leon Bax, Department of Medical Informatics, Graduate School of Medical Sciences, Kitasato University, Japan). 113, 114 
RESULTS

Postoperative Mortality
Twenty-three RDB trials reported data on postoperative death. 79,82-84,86,88,89,92-98,100-104,106-109 The overall postoperative mortality was low; only 19 patients (1%) died (8 [0.8%] in the treatment and 11 [1.1%] in the control group, respectively). In fact, 15 of 24 comparisons did not present any postoperative death event ("zero-sum" studies); therefore, the remaining 9 RDB trials (1,081 patients) 83 ,86,88,95,97,103,106-108 were used to perform the metaanalysis ( Table 3) . As shown in Figure 2A , the administration of steroid prophylaxis during cardiac surgery did not influence postoperative mortality (OR ϭ 0.71; confidence interval [CI], 0.29-1.73; p ϭ 0.46). This result is also confirmed by analyzing the methylprednisolone and dexamethasone subgroups.
Atrial Fibrillation
Fourteen of 31 RDB trials (1,344 patients) reported the incidence of postoperative atrial fibrillation. 83 One of these 88 had 2 treatment groups; therefore, 15 comparisons finally were analyzed (Table 3 and Fig 2B) . There were no "zero-sum" studies for this outcome. The overall incidence of atrial fibrillation was 31% (418 patients), 25.1% in treatment (172 patients) and 37.3% (246 patients) in the placebo group. Metaanalysis showed that steroid prophylaxis reduced the onset of postoperative atrial fibrillation (OR ϭ 0.56; CI, 0.44-0.72; p Ͻ 0.0001). In 5 of 14 trials, 86,93,102,103,107 a significant reduction of atrial fibrillation was observed, whereas none showed an increase of postoperative atrial fibrillation when steroids were administered. Subgroup analysis showed that this protective effect was related to dexamethasone administration (OR ϭ 0.56; CI, 0.39-0.79; p ϭ 0.001).
Postoperative Blood Loss and Re-exploration
Seven trials (399 patients) reported the amount of postoperative blood loss, 79,84,91,100,103,106,109 which was decreased by the administration of steroids (MD ϭ Ϫ204.2 mL; CI, Ϫ287.4 mL to Ϫ121 mL; p Ͻ 0.0001). Figure 3A shows that 6 of 7 trials reported reduced chest tube drainage in the treatment group; in 3 cases, this reduction was statistically significant. 79,84,100 The protective effect on blood loss also was confirmed in the methyl- prednisolone subgroup (MD ϭ Ϫ205.6; CI, Ϫ310.8 to Ϫ100.4; p ϭ 0.0001). Nevertheless, meta-analysis about re-exploration on 4 trials and 695 patients 95, 99 ,100,107 did not show any difference between treatment and placebo.
Postoperative Infections
Eleven RDB trials enrolling 1,002 patients reported the incidence of postoperative infections. 81, 85, 86, 94, 95, 100, 102, 103, 106, 108, 109 The overall incidence of postoperative infections was 2.5%; 2.7% in the treatment group, and 2.2% in the placebo group, respectively. Five of the RDB trials resulted in "zero-sum" trials. 81, 94, 100, 108, 109 In the remaining 6 RDB trials (710 patients), steroid prophylaxis did not increase the incidence of postoperative infections (OR ϭ 1.31; CI, 0.57-3.03; p ϭ 0.51). Nine trials reported data on wound infection, 81, 85, 94, 95 ,100,102,107-109 but 5 of these were "zero-sum" trials. In the remaining 4 RDB trials 85, 95, 102, 107 enrolling 641 patients, steroid prophylaxis did not affect the incidence of wound infection after cardiac surgery (OR ϭ 0.92; CI, 0.49-1.75; p ϭ 0.8).
Mechanical Ventilation
Twenty-one trials reported the time on mechanical ventilation after the operation. 82-86,88-90,92-97,99-101, 105, 106, 108, 109 No difference between treatment and placebo groups was observed (Table 3) . A trend for a reduced time on mechanical ventilation in steroid-treated patients was observed in the dexamethasone subgroup (8 trials, 712 patients) (MD ϭ Ϫ23 minutes; CI, Ϫ48 to 1.4 min; p ϭ 0.06).
ICU and Overall Hospital Length of Stay
Seventeen trials (882 patients) reported the ICU length of stay. 80, [84] [85] [86] [87] 89, 90, 92, 93, 97, 98, 100, 103, 105, 106, 108, 109 Meta-analysis of these trials revealed that steroid prophylaxis significantly reduced ICU stay (MD ϭ Ϫ6.7 hours; CI, Ϫ10.5 hours to Ϫ2.8 hours; p ϭ 0.0007). Figure 3B shows that all trials except 2 103,108 evidenced a lower ICU length of stay in the treatment groups; in 6 cases, this difference was statistically significant. 89, 92, 93, 97, 105, 106 This result also was confirmed when analyzing the methylprednisolone and dexamethasone subgroups (Table 3 ). The overall hospital length of stay was available in 15 trials [83] [84] [85] [86] [87] [88] 90, 97, 99, 102, 103, 105, 106, 108, 109 ; 1 of these trials had multiple treatment groups, 88 and, therefore, 16 comparisons were evaluated. Meta-analysis of these trials (Table  3) found that steroid prophylaxis reduced the overall postoperative length of stay (MD ϭ Ϫ0.8 days; CI, Ϫ1.4 days to Ϫ0.2 days; p ϭ 0.01).
Diabetic Patients
Among 31 trials included in the present meta-analysis, 6 studies excluded diabetic patients, 9 included only noninsulintreated diabetic patients, and 16 included both insulin-treated and noninsulin-treated patients. In the latter 16 trials, diabetic patients ranged between 15% and 30%, and the results of the meta-analysis were similar to those obtained on the whole 31 trials; except for mechanical ventilation wherein trials including diabetic patients receiving steroids did significantly better than placebo (Table 4) .
DISCUSSION
The first finding of the present systematic review was that the use of steroids during cardiac surgery is safe. In fact, none of the clinical outcomes analyzed was found to be worse in the treatment group. Because no clinical trial has been addressed yet regarding the clinical safety of steroids in cardiac surgery, this represents the best evidence on this topic at the moment.
Moreover, the perioperative use of steroids was not associated with an increased incidence of postoperative infection in a mixed population including diabetic patients. Unfortunately, because none of the trials was performed with only diabetic patients, it is not possible to assess the safety of steroids in this subgroup. Steroid-induced immune suppression has been considered potentially able to increase the risk of postoperative infections. This is one of the factors preventing physicians from administering steroids in cardiac surgery. The relationship between the postoperative inflammatory state and the predisposition to develop postoperative infections still requires specific physiopathologic investigations. However, in large observational studies, a direct correlation between the preoperative inflammatory state and postoperative infection has been documented, 115 ,116 and a possible explanation for the higher rate of postoperative infective complications in patients with high preoperative inflammatory status is based on the observation that bacterial growth is increased in the presence of elevated concentrations of proinflammatory mediators. 117 Another interesting result of this study is the effect of steroids on the onset of atrial fibrillation. An increasing body of evidence recently has highlighted the role of inflammation in the pathogen- esis of postoperative atrial fibrillation. 118, 119 The present metaanalysis confirmed that steroid prophylaxis reduced the incidence of postoperative atrial fibrillation by 30%. The present authors also observed that steroid prophylaxis reduces postoperative blood loss. Even though chest tube drainage removal timing and protocols may vary from trial to trial, the authors found that in 6 of 7 trials chest tube drainage was lower in the treatment group; it was statistically significant in 3 of these. 79,84,100 Approximately 20% of patients bleed significantly after cardiac surgery; the causes of this complication may vary from the presence of surgical bleeders to preoperative treatment with antiplatelet drugs to CPB-induced coagulopathy. 120 A significant interaction exists between inflammation and coagulation; this cross-talk leads to the activation of all major pathways involved in the pathogenesis of the hemostatic derangement observed during severe inflammation. 121 Because the activation of the inflammatory and coagulation systems presents similar pathways, 122 a better preservation of the coagulation system with reduced perioperative thrombin generation may be the cause of reduced postoperative bleeding in steroid-treated patients.
Chaney et al 83, 88 demonstrated the detrimental effects of methylprednisolone on pulmonary function and postulated the increase of pulmonary shunt and the A-a oxygen gradient as possible causes of prolonged mechanical ventilation in patients who were given methylprednisolone perioperatively. In the meta-analysis, the length of mechanical ventilation seemed not to be affected by steroid prophylaxis when trials using different steroids were pooled together. Nevertheless, when considering only trials using dexamethasone, a trend toward a shorter length of mechanical ventilation could be identified.
ICU and overall hospital lengths of stay were significantly reduced by steroid prophylaxis. The reduced length of stay in steroid-treated patients probably reflects the consequences of reduced postoperative bleeding; the incidence of atrial fibrillation; and, possibly, a general healthier state associated with a reduced postoperative inflammatory response.
The present systematic review has several limitations. The most important one is the significant variety of types and dosages of steroids used across the studies included. Although the analysis of postoperative mortality did not show any obvious difference between the treatment and control groups, the overall incidence of this event throughout the included trials is very low. A larger randomized trial should clarify this point, and it also would be essential to examine outcomes as neurologic or gastrointestinal complications that were not considered in the present review because of the excessive heterogeneity of their definitions. Moreover, the trials included in the analysis are from a 30-year span, and the difference in medications, techniques, and demographics may have had a significant effect on the outcomes measured.
The lack of data regarding the outcome in diabetics should limit the use of steroids in this subset of patients. The very low risk profile of the patients enrolled in the RDB trials included (80% isolated CABG surgery) suggests that the conclusions of this meta-analysis cannot be automatically extended to high-risk patients although patients with complex procedures and long CPB times may benefit more from the use of steroids.
Recently, Whitlock et al 123 published a meta-analysis reporting similar results on the effects of steroids in patients undergoing cardiac surgery. However, there are differences between the 2 studies. The most important is the exclusion in the present meta-analysis of open-label trials. Even if this choice reduced the number of trials included, the quality of the analysis was higher (mean Jadad score, 3.5 Ϯ 0.9 v 2.7 Ϯ 1.4). Another difference was the observed mortality (1% v 3.2%), which may reflect a different case mix of patients enrolled (80% v 70% of isolated CABG surgery). Even with the higher mortality and sample size of the Whitlock series, they found no difference in hospital mortality. Moreover, to reduce the heterogeneity caused by the use of different types of steroids, the authors repeated the analysis for the 2 most represented molecules (dexamethasone and methylprednisolone), finding that the use of dexamethasone only is associated with the protective effect on atrial fibrillation. Considering that dexamethasone is long lasting and does not present any mineralcorticoid effect (potentially creating fluid and electrolytes imbalance) compared with methylprednisolone, future studies should identify the best steroid compound for cardiac surgery. The authors deliberately decided not to include outcomes like postoperative myocardial infarction, neurologic complications, and gastrointestinal complications because of the lack of precise definitions throughout the trials.
In conclusion, the present meta-analysis of RDB trials shows that steroid prophylaxis is generally safe and effective at reducing the incidence of some postoperative complications after cardiac surgery. A forthcoming large randomized clinical trial (http:// www.clinicaltrials.gov/ct2/show/NCT00427388) will probably be able to evaluate the unanswered questions left by the present study. 
